Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
-
Published:2018-11
Issue:
Volume:Volume 5
Page:109-119
-
ISSN:2253-5969
-
Container-title:Journal of Hepatocellular Carcinoma
-
language:en
-
Short-container-title:JHC
Author:
Azim Hamdy,
Omar Ashraf,
Atef Hesham,
Zawahry Heba,
Shaker Mohamed KORCID,
Abdelmaksoud AH KamelORCID,
EzzElarab Mohamed,
Abdel-Rahman OmarORCID,
Ismail Mohamed,
Kassem LoayORCID,
Waked ImamORCID
Publisher
Informa UK Limited
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献